NSTK · 01.2026Independent supplement reference

Edition 1.0Updated August 1, 2026

Supplement × Prescription·Evidence index

Fluvoxamine and L-Tryptophan: what the published research says

PubMed indexes 6 records that name Fluvoxamine and L-Tryptophan together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Reviews & meta-analyses

Read the studies ↓ How we select sources

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Fluvoxamine and L-Tryptophan. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

A study appearing here is not proof that an interaction exists. Two substances can be named together in a paper that never tested them in combination, and a source listed as background may cover only one of them.
Findings are quoted from each abstract as the authors wrote them. NutriStack has not re-analysed, pooled, or reconciled them, and they may disagree with each other.
NutriStack’s own interaction assessment for this pair is not published here. It has not completed qualified-human clinical review, so it is withheld from search. See the publication gate.
Nothing here is medical advice. Decisions about prescription medication and supplements belong with your prescriber or pharmacist, who can see your full regimen.

The research

6 studies naming Fluvoxamine and L-Tryptophan.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

Molecular psychiatry · 2001 · PMID 11526473

Clinical TrialRandomized Controlled Trial

Names both Fluvoxamine and L-Tryptophan in its title.

Fluvoxamine treatment of dementia: tryptophan levels.

Biological psychiatry · 1993 · PMID 8274593

Clinical TrialLetter

Names both Fluvoxamine and L-Tryptophan in its title.

Effects of desipramine and fluvoxamine treatment on the prolactin response to tryptophan. Serotonergic function and the mechanism of antidepressant action.

Archives of general psychiatry · 1989 · PMID 2500111

Clinical TrialComparative StudyControlled Clinical Trial

Names both Fluvoxamine and L-Tryptophan in its title.

Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats.

Psychopharmacology · 2007 · PMID 17318509

Animal study

“We demonstrated that chronic treatment with milnacipran or fluvoxamine was effective to improve both the hyperemotional behavior and the loss of TPH-positive cells seen in OBX rats.”
Saitoh et al. · Authors' conclusion

Names both Fluvoxamine and L-Tryptophan in its title.

Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder.

Progress in neuro-psychopharmacology & biological psychiatry · 2002 · PMID 12502014

Human subjects

“Fifty-four patients completed the study. The present study fails to demonstrate that the genetic polymorphisms of MAOA-VNTR and TPH-A218C affect the antidepressant effect of fluvoxamine in Japanese patients with major depressive disorder.”
Yoshida et al. · From the abstract

Names both Fluvoxamine and L-Tryptophan in its title.

Reduction of serotonergic function in rat brain by tryptophan depletion: effects in control and fluvoxamine-treated rats.

Journal of neurochemistry · 1996 · PMID 8764594

Animal study

Names both Fluvoxamine and L-Tryptophan in its title.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

Selection. These records were found by searching PubMed titles and abstracts for both substance names alongside interaction and pharmacokinetic terms. Relevant work that phrases things differently, or is not indexed in PubMed, will be missing.
No effect size. The quoted conclusions are the authors’ words about their own study. We have not extracted effect direction or magnitude, and a single study’s conclusion is not a consensus.
Population mismatch. Findings in healthy volunteers, animals, or a specific patient group may not transfer to you, your dose, or your formulation.
Absence is not safety. Few published studies means the combination is under-studied, which is not the same as established as safe.

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Fluvoxamine, L-Tryptophan, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

Get NutriStack free → Read the methodology

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.